Form 4 for FBIO Fortress Biotech, Inc.
Accepted 2023-08-21 00:00:00 ET · period of report 2023-08-17 · accession 0001104659-23-093700 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| M | 2023-08-21 | 2023-08-17+ | FBIO | ROSENWALD LINDSAY A MD | Pres, CEO, COB, Dir, 10% | P - Purchase | $10.54 | +20.0K | 112.5K | +22% | +$210.9K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | SERIES A CUMULATIVE PERPETUAL PREFERRED STOCK | 2023-08-17 | P | A | 10,000 | $11.75 | 102,500 | D | — | — | |
| 2 | Common | SERIES A CUMULATIVE PERPETUAL PREFERRED STOCK | 2023-08-18 | P | A | 10,000 | $9.34 | 112,500 | D | — | — |